Vericel (VCEL) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY25 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. AMZN
2. INTC
3. PINS
4. COIN
5. RDDT
6. FSLR
7. FND
8. RIVN
9. SBUX
10. SNDK

Go back to Vericel (VCEL) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY25 Revenue Guidance

Vericel Reports Third Quarter 2025 Financial Results

November 6, 2025 7:55 AM EST

Record Third Quarter Total Revenue of $67.5 Million

MACI Revenue Growth of 25% to $55.7 Million

Net Income of $5.1 Million and Adjusted EBITDA Margin of 25%

Record Third Quarter Operating Cash Flow of $22.1 Million

More than 800 MACI Arthro Surgeons Trained to Date

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn... More